In Partnership with:

Richmond Times-Dispatch

Food and Drug Administration

5519 Stories, most recent news story added 3 minutes ago

BioVex Said to Snag Another $30 Million

New York Times - Tue Nov 10, 6:56 am ET

BioVex , a Woburn, Mass.-based biotechnology company that raised $40 million in venture capital in March to develop a novel cancer-fighting treatment, plans to announce Tuesday that it has raised another $30 million, The Boston Globe reported.